HRMVX | VMVAX | HRMVX / VMVAX | |
Total Expense Ratio | 1.10 | 0.07 | 1,571% |
Annual Report Gross Expense Ratio | 1.15 | 0.07 | 1,643% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 11.459 | 6.882 | 167% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 3000 | 1,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 374M | 32B | 1% |
Annual Yield % from dividends | 0.96 | 2.15 | 45% |
Returns for 1 year | 8.91 | 7.20 | 124% |
Returns for 3 years | 27.16 | 29.26 | 93% |
Returns for 5 years | 73.49 | 67.70 | 109% |
Returns for 10 years | 54.41 | 101.90 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DEXC | 55.17 | 0.33 | +0.60% |
Dimensional Emerging Markets ex China Core Equity ETF | |||
PNF | 6.80 | N/A | N/A |
PIMCO NEW YORK Municipal Income FUND | |||
WDNA | 14.47 | N/A | N/A |
WisdomTree BioRevolution ETF | |||
SEPW | 31.05 | -0.01 | -0.02% |
AllianzIM U.S. Large Cp Buffer20 Sep ETF | |||
ILCB | 89.77 | -0.26 | -0.29% |
iShares Morningstar U.S. Equity ETF |